PCI Biotech: Fourth quarter and preliminary full year 2015 results NewsRonny SkuggedalFebruary 9, 2016
PCI Biotech and Ultimovacs initiates preclinical research collaboration NewsRonny SkuggedalJanuary 27, 2016
Dose escalation in the bile duct cancer study completed with promising early signs of efficacy NewsRonny SkuggedalJanuary 22, 2016
PCI Biotech strengthens the organisation by appointing world leading experts to inaugural Scientific Advisory Committee NewsRonny SkuggedalOctober 16, 2015
PCI Biotech to present at the Oligonucleotide Therapeutics Society (OTS) 11th Annual Meeting NewsRonny SkuggedalOctober 13, 2015
Presentation of PCI Biotech’s bile duct study at the annual German Gastroenterology Congress 2015 NewsRonny SkuggedalSeptember 18, 2015
PCI Biotech signs pre-clinical research collaboration agreement with a top-10 large pharma company NewsRonny SkuggedalSeptember 10, 2015
PCI Biotech announces activation of Oslo University Hospital as a new clinical site NewsRonny SkuggedalAugust 31, 2015
Successful completion of the third dose cohort in the study for patients with inoperable bile duct cancer NewsRonny SkuggedalAugust 18, 2015
